Indivior Pharmaceuticals Inc
INDV
Clasificación en acciones
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Precio por acción
$34.01
Última sincronización: 2026-10-19
Capitalización bursátil
$4.24B
Cambio (1 día)
4.81%
Cambio (1 año)
40.02%
País
US
Comercio Indivior Pharmaceuticals Inc (INDV)
Categoría
Healthcare
Ratio P/B de Indivior Pharmaceuticals Inc (INDV)
Ratio P/B al October 2026 TTM: -20.59
Según los informes financieros más recientes y el precio de las acciones de Indivior Pharmaceuticals Inc, el ratio P/B actual (TTM) es -20.59. Al final de 2023, el ratio P/B era 31.28.
Historial del ratio P/B de Indivior Pharmaceuticals Inc desde 2016 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
